Early research (Phase 1)Study completedNCT06460064
What this trial is testing
First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP
Who this might be right for
Influenza
Sumitomo Pharma Co., Ltd. 144